Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

Five Facts about Breast Cancer

October 2, 2025 Medical Communications Breast Cancer Awareness Month, Five Facts, Oncology, breast cancer

1 There are striking inequities in breast cancer burden regarding the Human Development Index (HDI), the United Nation’s measure of …
Feature
drug-trials

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence

September 19, 2025 Medical Communications, Research and Development LGC Group, biotech, life sciences, pharma

LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of Excellence in Ontario, Canada after …
News
Lilly secures conditional MHRA approval for new blood cancer treatment

Crown Bioscience opens new US model development centre

September 19, 2025 Medical Communications, Research and Development CRO, biotech, crown bioscience, life sciences

Crown Bioscience, a US global contract research organisation (CRO) that is part of JSR Life Sciences and Japan-based JSR Corporation, …
News

UCB announces first-in-patient trial success for galvokimig in atopic dermatitis

September 18, 2025 Medical Communications, Research and Development Dermatology, UCB, atopic dermatitis, clinical trial

UCB has reported positive early clinical trial results for galvokimig, an investigational therapy for adults with moderate-to-severe atopic dermatitis (AD). …
News
Lilly secures conditional MHRA approval for new blood cancer treatment

Symeres announces acquisition of DGr Pharma

September 11, 2025 Medical Communications, Research and Development DGr Pharma, Symeres, biopharma, contract research

Symeres, a Contract Research, Development and Manufacturing Organization (CRDMO) has acquired DGr Pharma, a drug development-focused consultancy. The acquisition will …
News

Danny Wolin appointed as KJT’s Senior VP of real-world evidence

September 11, 2025 Medical Communications, Research and Development KJT, real-world evidence

Danny Wolin has been appointed as Senior Vice President of Real-World Evidence at KJT. KJT is an evidence-based healthcare consulting …
Appointment

Sapio Sciences and Ultima Genomics form multi-omics research partnership

September 11, 2025 Medical Communications, Research and Development Sapio Sciences, Ultima Genomics, biotech, genomics research

Sapio Sciences and Ultima Genomics have formed a strategic partnership to accelerate genomics research. The collaboration aims to make multi-omics …
News
drug-trials

MultiOmic Health and BIO4 Campus sign collaborative Memorandum of Understanding

September 8, 2025 Medical Communications, Research and Development AI, BIO4 Campus, Memorandum of Understanding, MultiOmic Health, biotech

MultiOmic Health (MOH), an artificial intelligence (AI)-enabled precision medicine biotechnology company and BIO4 Campus (BIO4), a biotechnology and life sciences …
News

Rare and severe epilepsies – current treatments and advance therapeutics

August 29, 2025 Medical Communications, Research and Development Neurology, UCB, epilepsy, epilepsy treatment, rare epilepsies

The current forms of immunotherapy, how T cell therapy works and what the future holds
Feature
hospital

The Pharma Files: With Professor Hatim Abdulhussein from Health Innovation Kent Surrey Sussex

August 28, 2025 Medical Communications, Research and Development Corporate, GP, Health Innovation Kent Surrey Sussex, The Pharma Files

Pharmafile chats with Priyanka Hinton, Customer Solutions Director at Chase People about the best parts of her job and her …
Feature

How pharma marketing needs to adapt as community pharmacies take centre stage

August 28, 2025 Business Services, Medical Communications, Sales and Marketing 10 Year Health Plan, Pharmacy, m3, pharmacy

The UK government’s 10-Year Health Plan is moving pharmacists to the frontline of primary care For decades, community pharmacies were …
Feature

European Commission approves HIV prevention injection

August 28, 2025 Medical Communications, Research and Development European Commission, Gilead Science, HIV, HIV/AIDS, US Food and Drug Administration, World Health Organisation

The European Commission (EC) has granted marketing authorisation for Gilead Science’s Yeytuo (lenacapavir), the first twice-yearly injectable medicine approved in …
News

EMA grants orphan drug designation for Roca’s treatment of radiation maculopathy

August 28, 2025 Medical Communications, Research and Development European Medicines Agency (EMA), Oncology, Opthalmology, Roca Therapeutics, maculopathy

The European Medicines Agency (EMA) has granted Orphan Drug Designation to Roca Therapeutics for its lead candidate RCT002, marking the …
News
hsm_mobile_clinical_trial_istock-872676342

FDA approves Wegovy for treatment of MASH in adults with liver fibrosis

August 22, 2025 Medical Communications, Research and Development Hepatology, Novo Nordisk, US Food and Drug Administration, clinical trial, hepatitis, obesity

The US Food and Drug Administration (FDA) has granted accelerated approval for Wegovy (semaglutide) as a treatment for adults with …
News
epilepsy-623346_960_720

Epilepsy Research Institute opens 2025-26 grant round with new awards

August 21, 2025 Medical Communications, Research and Development Neurology, epilepsy, funding programme, medical research

The Epilepsy Research Institute has opened its 2025-26 Grant Round, offering a wide range of funding opportunities designed to support …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025